Literature DB >> 31953098

Angiocentric glioma: Drop Metastases to the Spinal Cord.

Philip J O'Halloran1, Michael Amoo2, Mohamed O Dablouk2, Alan Beausang3, Stephen MacNally2.   

Abstract

BACKGROUND: Angiocentric glioma (AG) is an epileptogenic low grade (World Health Organization grade I) glial tumor with astrocytic and ependymal differentiation, most commonly affecting the pediatric and adolescent population. Despite its infiltrating histological growth kinetics, it is widely accepted that AG has a low potential for aggressive behavior. CASE DESCRIPTION: We present the case of a 42-year-old man who represents the first documented case of not only extracranial manifestation of AG, but also spinal metastatic dissemination. Our patient initially presented with a generalized tonic clonic seizure; following a biopsy, he was diagnosed with a low-grade supratentorial astrocytoma and subsequently received fractionated radiotherapy. He presented 10 months later with worsening dorsal column symptoms and was found to have a contrast-enhancing intradural extramedullary lesion that was surgically resected and histologically confirmed as an AG.
CONCLUSION: Further research is required to examine the microenvironment and potential for malignant change in this tumor.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiocentric glioma; Extracranial; Metastases; Neuro-oncology

Year:  2020        PMID: 31953098     DOI: 10.1016/j.wneu.2020.01.037

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  2 in total

1.  Cystic angiocentric glioma: a case report and literature review.

Authors:  Qiqi Wang; Yubo Xiong; Jun Chen; Qiang Shao
Journal:  Childs Nerv Syst       Date:  2020-09-26       Impact factor: 1.475

Review 2.  Neuroimaging features of angiocentric glioma: A case series and systematic review.

Authors:  Ryo Kurokawa; Akira Baba; Pinarbasi Emile; Mariko Kurokawa; Yoshiaki Ota; John Kim; Aristides Capizzano; Ashok Srinivasan; Toshio Moritani
Journal:  J Neuroimaging       Date:  2022-02-24       Impact factor: 2.324

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.